New pain block after heart surgery may cut morphine use and chronic pain

NCT ID NCT05885230

Recruiting now Symptom relief Sponsor: Beni-Suef University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests two ways to manage pain after heart surgery: an ultrasound-guided nerve block using bupivacaine, or a continuous lidocaine infusion. It involves 138 adults undergoing planned heart surgery. The goal is to see which method reduces morphine use in the first 24 hours and lowers the chance of long-term pain.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: bupivacaine and lidocaine
What this could lead to: If successful, this could provide a better way to manage pain after heart surgery, potentially reducing the need for morphine and lowering the risk of chronic pain.
What could go wrong: This is a small, early-stage trial with 138 participants. Results may not apply to all heart surgery patients, and both methods carry risks like allergic reactions or nerve damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIAC SURGERY

Contacts and locations

Locations

Benisuef University Hospital
RECRUITING

Banī Suwayf, e\EYGPT, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.